The G4C2 hexanucleotide repeat expansion (HRE) in C9orf72 is the commonest cause of familial amyotrophic lateral sclerosis (ALS). A number of different methods have been used to generate isogenic control lines using CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 and non-homologous end-joining (NHEJ) by deleting the repeat region with the risk of creating indels and genomic instability. In this study we demonstrate complete correction of an induced pluripotent stem cell (iPSC) line derived from a C9orf72-HRE positive ALS/FTD patient using CRISPR/Cas9 genome editing and homology directed repair (HDR), resulting in replacement of the excised region with a donor template carrying the wild-type repeat size to maintain the genetic architecture of the locus. The isogenic correction of the C9orf72 HRE restored normal expression and methylation at the C9orf72 locus, reduced intron retention in the edited lines, and abolished pathological phenotypes associated with the C9orf72 HRE expansion in iPSC derived motor neurons (iPSMNs). RNA sequencing of the mutant line identified 2220 differentially expressed genes compared to its isogenic control. Enrichment analysis demonstrated an overrepresentation of ALS relevant pathways, including calcium ion dependent exocytosis, synaptic transport and the KEGG ALS pathway, as well as new targets of potential relevance to ALS pathophysiology.
Introduction
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and uniformly fatal adultonset neurodegenerative disorder characterized by loss of motor neurons (MNs) in the brain and spinal cord, with an average survival of approximately 2.5 years from symptom onset [1] . The clinical, genetic and pathological overlap with frontotemporal dementia (FTD) is now well established [2] . A hexanucleotide repeat expansion (HRE) mutation in the C9orf72 gene is responsible for 35-40% of cases of familial ALS (fALS), 5-7% of sporadic ALS (sALS), and approximately 25% of cases of familial frontotemporal dementia (fFTD) in populations of Northern European genetic heritage [3, 4] . The hexanucleotide expansion is located in a non-coding region of the gene which forms either the upstream promoter or the first intron of C9orf72 transcripts. The number of (G 4 C 2 ) n hexanucleotide repeats in affected individuals is typically more than 1000 [5, 6] .
Multiple mechanisms of C9orf72-HRE toxicity have been proposed. The accumulation of (G4C2) n transcripts in RNA foci in neuronal nuclei may lead to the sequestration of RNA binding proteins, with disruption of RNA handling or induction of nucleolar stress. Repeat-associated non-ATG (RAN) translation across the G4C2 repeat expansion in both sense and antisense directions produces aggregation-prone, potentially toxic, poly-dipeptide repeats (DPRs) [7, 8] . In addition, hexanucleotide repeat expansions result in transcriptional downregulation of C9orf72 mRNA and reduced protein levels in affected regions of the brain of ALS/FTD patients [9] , suggesting that haploinsufficiency may also contribute to the phenotype.
RNA foci and RAN-translation products can be detected in induced pluripotent stem cell (iPSC)-derived motor neurons (iPSMNs) derived from patients with C9orf72 hexanucleotide expansions, in association with varied phenotypes, including altered neuronal excitability, sequestration of RNA-binding proteins, increased endoplasmic reticulum (ER) stress and defects in nucleocytoplasmic transport and autophagy [10] [11] [12] [13] [14] [15] [16] .
A key challenge in using techniques such as RNA sequencing for the identification of disease mechanisms using iPSC neuronal models is that inherent biological variance arising from differences in genetic background, clonal selection, and inconsistencies in reprogramming and differentiation protocols, may be greater than the expression changes due to a disease-causing mutation. Genome editing techniques, such as CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 and zincfinger nuclease mediated-gene targeting, have been employed to remove point mutations in iPSCs from an ALS patients with SOD1 mutations and in iPSCs from an FTD patient with a progranulin mutation, to create isogenic control lines [17] [18] [19] [20] .
Recently, the successful excision of C9orf72 (G4C2) n using CRISPR/Cas9 technology has also been reported, yielding isogenic lines with a missing repeat region [16] .
Here, we report the generation of isogenic iPSC line from an ALS/FTD patient carrying an expansion of 1000 G4C2 repeats in C9orf72 using CRISPR/Cas9-mediated HDR to replace the pathogenic expansion with a donor template carrying a normal repeat size of (G4C2) 2 . To reduce the possibility of off-target mutations and improve on-target specificity, a double-nicking approach with the D10A mutant nickase version of Cas9 (Cas9n) was used [21] . In MNs differentiated from the corrected iPSC lines, we demonstrate the correction of pathological markers of the C9orf72 HRE, such as sense and antisense RNA foci and dipeptide toxicity. We also demonstrate restoration of C9orf72 transcript expression and methylation to levels seen in normal controls. Using RNA sequencing, we identify dysregulation of ALS relevant pathways specific to lines carrying the expansion, including glutamate excitotoxicity and cell death and the functional validation of selected pathways in the corrected cell lines. This study therefore demonstrates that HDR-mediated correction in patient-derived iPSCs can lead to the generation of induced MN-like cells that display features characteristic of normal cells, which has the advantage over other techniques of generating a more precise isogenic control line free of indels.
Materials and Methods
Fibroblast reprogramming. Skin fibroblasts obtained from an ALS/FTD patient (C9-02) carrying the (G4C2) n repeat expansion mutation in the C9orf72 gene, confirmed by repeat primed PCR and Southern blotting, were used to generate two iPSC lines (C9-02-02 & C0-02-03) using the CytoTune-1-iPSC reprogramming kit (Life Technologies), as previously described [10] . Ethical approval for the collection and use of these cells was obtained from the South Wales Research Ethics Committee (approval number: 12/WA/0186).
Karyotyping. Genomic DNA was extracted using the DNeasy kit (QIAGEN). Genome integrity for iPSC lines and their corresponding fibroblasts was assessed using the Human OmniExpress24 array (~700,000 markers, Illumina) and analysed using KaryoStudio software (Illumina).
CRISPR/Cas9 gRNA construct preparation and guide RNA construction. Guide-
RNAs (gRNA1 and gRNA2) were designed to target a sequence 140 bps upstream of the repeat region. All PCR reactions were done using Phusion High Fidelity DNA Polymerase (Thermo Fisher Scientific) in a 50 μ l total volume. Sanger sequencing was performed by Source BioScience (Oxford, United Kingdom). Oligo sequences for gRNA synthesis are listed in Supplementary Table 2 . gRNA synthesis was performed using the pX335 vector (Addgene, Plasmid #42335) containing a D10A nickase for the co-expression of SpCas9 and gRNA, following a published protocol [22] . For the construction of gRNA 1&2, the pX335 vector was linearized with BbsI and gelpurified. The two oligos for each gRNA were annealed, phosphorylated, and ligated into the pX335 vector. The vector was then transformed into Stabl2 E Coli and DNA minipreps were prepared and sequenced to check for the presence of correct gRNA sequences. Finally, two midipreps were prepared for successfully constructed gRNA 1 & 2.
Design of homology-directed repair template
The DNA regions upstream and downstream of the repeat were assessed individually for the presence of any single nucleotide polymorphisms (SNPs) using two sets of specific primers listed in Supplementary Table 3 . The left and right homology arms were amplified from the wild-type allele of the same patient DNA (C9-02), which contains two G4C2 repeats. Supplementary Table 3 . Two RP-PCRs were performed, RP-PCR1 to assess the presence of the repeats on the 5' direction, and RP-PCR2 to assess the presence of the repeats on the 3' direction. RP-PCR assays were performed as previously described with a brief modification on the primer sequences [9, 23] . Both and then, PCR fragments were visualised on 2% agarose gel electrophoresis to confirm the insertion of Nsi1 sites.
Removal of Puro/Tk cassette using Cre-Lox P system. To excise the selection cassette, iPSCs from one of the heterozygous targeted clones (Ed-02) and one homozygous clone (Ed-03) were nucleofected using Cre mRNA following the same nucleofection experiment as described above. iPSCs were nucleofected with 0.5 μ g Cre mRNA and seeded on 10 cm plates pre-coated with MEFs and maintained in hES supplemented with 10 μ M Y-26732 and no antibiotics. After few days of nucleofection, cells were treated with 3 μ g/ml Ganciclovir added directly to the feeding media. After Supplementary Table 3 .
Southern Blot. Southern blotting was applied on genomic DNA derived from edited cells, healthy controls and diseased cells. Briefly, DNA was extracted with DNeasy
Blood & Tissue kit and 5-10 μ g of genomic DNA was digested overnight at 37°C with AluI-and DdeI. Then digested samples were separated by electrophoresis on 0.8% agarose gel, and then transferred overnight to a positively charged nylon membrane by capillary blotting (Roche Applied Science). In the next day, membrane was cross-linked by UV irradiation, and hybridized overnight at 55°C with 1 ng/ml digoxigenin-labelled (GGGGCC) 5 oligonucleotide probe (Integrated DNA Technologies) in 25 ml hybridization reaction (EasyHyb Granules, Roche). Following denaturation of the probe at 95°C for 5 min, probe was snap cooled on ice for 30 seconds and immediately added to the prehybridised membrane. The following day, the membrane was washed twice with stringency washes (2X Saline-Sodium Citrate buffer (SSC) and 0.1% sodium dodecyl sulfate (SDS), each for 15 minutes at 65°C in the hybridisation oven. The membrane was then washed twice at the same temperature and conditions with 1X SSC and 0.1% SDS and finally washed twice with 0.5X SSC and 0.1% SDS for further 15 minutes at room temperature. The membrane was washed with 1X wash buffer (Roche Applied Science) for 2 minutes, then incubated with blocking solution (Roche Applied Science) for 1-2 hours. After that, the membrane was incubated with Anti-DIG-AP Fab fragments (Roche) for 25-30 minutes and washed three times with 1X washing buffer.
Ready-to-use CDPD (Roche Applied Science) chemiluminescent substrate was added to the membrane and signals were visualised on Detection Film. All samples were compared to DIG-labelled DNA molecular-weight markers II (Roche Applied Science) and repeat number was estimated compared to the DNA marker sizes.
Differentiation of iPSCs to motor neurons. iPSCs were differentiated to mature motor neurons (iPSMNs) using a previously described protocol [10] , which was adapted with minor modification from the protocol described by Maury et. al [24] . Briefly, the iPSCs were grown on Matrigel until confluency, then neural induction was started using DMEM/F12:Neurobasal 1:1, N2, B27, ascorbic acid (0.5 mM), 2-mercaptoethanol, compound C (3 µM) and Chir99021 (3 µM). After 4 days in culture, RA (1 µM) and SAG (500 nM) were added to the medium. On the next day, Chir99021 and compound C were removed from the medium, and the cells were cultured for another 4-5 days.
After that, cells were split 1:3 on approximately day 10. Subsequently, the medium was supplemented with growth factors BDNF (10 ng/mL), GDNF (10 ng/mL), N-[N-(3,5-Difluorophenacetyl)-L-ala-nyl]-S-phenylglycine t-butyl ester (DAPT) (10 mM), and laminin (0.5 mg/mL). After 7 days, DAPT and laminin were removed from the medium, and the neurons were allowed to mature until day 25-30. RNA fluorescence in situ hybridization (FISH). RNA fluorescence in situ hybridisation (FISH) was performed using modified methods previously published [28] . washes and fluorescent secondary antibody incubation (Licor 800CW and 680RD, 1:10,000). Membranes were visualised in a ChemiDoc imaging system (BioRad).
Immunofluorescence

Data analysis and statistics for molecular biology experiments. Statistical analyses
and data visualisations other than for sequencing analysis were performed using GraphPad Prism.
Results
CRISPR/Cas9-mediated gene editing of the C9orf72 G4C2 repeat expansion
Skin fibroblasts obtained from an ALS/FTD patient (C9-02) carrying an expansion of 1000 G4C2 hexanucleotide repeats in C9orf72 were used to generate two iPSC lines (C9-02-02 & C9-02-03) as previously described [10] . To correct the HRE mutation and generate isogenic lines, double-nicking CRISPR/Cas9 and HDR was applied to the C9-02-02 iPSC line using a double-stranded DNA (dsDNA) plasmid donor template harbouring two G4C2 repeats and containing two long homology arms flanking each side of the target site, to replace the large repeat expansion (~1000 repeats) via homologous recombination. A puromycin/TK selection-counterselection cassette was inserted ~53bp upstream of the repeat region, driven by an EF1a promoter and flanked by two LoxP sites, to facilitate screening and isolation of the corrected clones (Fig. 1A) . The cleavage efficiency of the two guide RNAs was evaluated using a T7E1 cleavage assay after transfecting HEK293T cells with either individual gRNAs or with both gRNAs at the same time. The cleavage assay allowed the detection of double-strand breaks, indicated by the presence of heteroduplex DNA (Suppl. Fig. 1A ). This demonstrates that both gRNAs were able to introduce DSBs when applied simultaneously, ensuring that they could be used in the subsequent editing experiments in iPSCs.
Following nucleofection of the C9-02-02 line, puromycin selection was performed and around 100 colonies were isolated and evaluated by repeat-primed PCR to confirm the elimination of the expanded hexanucleotide in 24 clones as indicated by the normal electropherogram profile (Fig. 1B) . Sanger sequencing of the repeat region confirmed correct replacement by the donor template in two heterozygous (2% monoallelic) and three homozygous clones (3% bi-alleic) (Suppl. Fig. 1B) . The specific integration of the donor template at the 5' and 3' junctions was also evaluated by direct sequencing and restriction fragment length polymorphism (RFLP), confirming specific integration of the donor template (Suppl. Fig. 1C ). Bi-allelic clones were excluded due to the manipulation of both alleles with the donor template.
Cre/LoxP mediated excision and negative selection with ganciclovir yielded multiple isogenic lines free of the selection marker, as confirmed by PCR using primers inside the cassette and outside the 5' homology arm (Suppl. Fig. 1D ). After that, two sub clones, Ed-02-01 and Ed-02-02 were selected and the repeat region was amplified and sequenced, confirming the absence of the repeat and presence of the remaining LoxP site in the targeted alleles (Suppl. Fig. 1E&F ). The absence of the 6kb expansion in the edited isogenic lines was further confirmed using Southern blotting analysis (Suppl. Fig. 1G ). These sequencing results confirmed the presence of the normal repeat size derived from HDR and demonstrating successful editing of HRE mutation by CRISPR/Cas9 system in iPSCs.
Immunostaining of pluripotency markers (NANOG, OCT4 and TRA-1-60) after gene editing showed that Ed-02-01 and Ed-02-02 iPSCs retain normal expression of these markers (Suppl. Fig. 1H ). Karyotyping of Ed-02-01 and Ed-02-02 also revealed that both lines retained their normal chromosomal profile when compared to the parental iPSCs (C9-02) ( Fig 1C) . Immunostaining for motor neuron specific differentiation markers Olig2 and Islet1 on Day 20, and Islet-1, HB9, SMI-32, and ChAT at day 30 showed that the gene editing process had no effect on motor neuron differentiation ( Fig. 2A&B) , with similar morphology and differentiation efficiencies seen in all differentiated lines ( Fig. 2C-F ).
CRISPR/Cas9 genome editing restores normal C9orf72 expression and DNA promoter methylation levels
Since the HRE in C9orf72 has previously been shown to reduce the expression of C9orf72 in iPSC-derived motor neurons, we sought to establish whether normal regulation of expression had been restored by CRISPR/Cas9 genome editing.
Quantitative RT-PCR with primers amplifying all C9orf72 RNA isoforms and the individual variants revealed that total C9orf72 RNA levels and the levels of the V1 and V2 mRNA variants were reduced in C9-02-02 and C9-02-03 compared to the normalised levels in Ed-02-01 and Ed-02-02, which showed similar levels to WT-01 and WT-02 (p < 0.001, One-Way ANOVA) (Fig. 3A) .
Previous studies have also shown that C9orf72 gene expression may be reduced by repeat-associated methylation of the CpG promoter [37, 38] . To evaluate methylation levels upstream of the repeat, we performed a methylation sensitive restriction enzyme-qPCR which has previously been described [25, 26] . Restriction digestion of the CpG site by HhaI and HpaII occurs in the absence of CpG DNA methylation.
Quantification of the digested DNA derived from both enzymes showed that CpG methylation was higher in C9-02-02 and C9-02-03 patient lines compared to WT-01 and WT-02 healthy controls and Ed-02-01 and Ed-02-02 lines for HhaI (p< 0.0001) and HpaII digestion (p < 0.0001) (Fig. 3B) .
In order to ascertain the methylation status of multiple CpG sites within the 5' CpG island region of C9orf72, genomic DNA samples isolated from iPSMNs clones were treated with sodium bisulfite and subjected to PCR using primers specific to the 5' Using this method, all 26 CpG residues from iPSC motor neuron clones derived from
C9orf72 HRE-positive patients were found to be methylated (>50% mC). In contrast, the same CpG residues were found to be unmethylated (< 30% mC) in control iPSMNs clones and in edited clones. Notably, the majority (86%) of CpG residues in the analysed samples were either 100% or 0% methylated. CpG 1 was the site most likely to have a mixed methylation pattern, being mixed in every sample tested. Note that in this assay, CpG 2 corresponds to the site assayed by the methylation-sensitive restriction digestion assay (Fig. 3C ).
Collectively these results suggest that gene editing of the repeat expansion resulted in normalisation of C9orf72 gene expression levels through restoration of normal methylation patterns.
RNA foci and polydipeptides are abolished in CRISPR/Cas9 corrected iPSMNs
The presence of RNA foci and toxic polydipeptides are established neuropathological hallmarks of the C9orf72 HRE expansion and can be detected in iPSMNs derived from affected patients. We evaluated the presence of sense and antisense RNA foci in the iPSMNs using fluorescence in situ hybridisation (FISH). Both sense and antisense RNA foci were seen in motor neurons derived from C902-02 and C9-02-03 patient lines but were absent from healthy controls WT-01 and WT-02 and edited clones Ed-02-01 and Ed-02-02 ( Fig. 4A-C) .
To examine whether the edited MNs rescue the formation of RAN-dipeptides (DPs), we performed a dot-blot analysis of the GA, GP, and GR polydipeptides using protein samples from all experimental lines. Higher concentrations of the DPs were detected in iPSMNs of C9-02-02 and C9-02-03 lines compared to healthy and edited lines ( Fig. 4D) . These results confirm that removal of the G 4 C 2 HRE successfully corrects the typical pathology of nuclear RNA foci and cytoplasmic dipeptides in iPSMNs.
CRISPR/Cas9 correction improves cell survival and the response to cellular stress
In previous work we identified increased susceptibility of C9orf72 HRE positive iPSMNs to apoptosis in basal conditions [10] . In this study we confirmed increased levels of cleaved caspase3 in C9orf72 HRE positive iPSMNs using immunofluorescence imaging and demonstrate that edited iPSC-derived motor neurons, Ed-02-01 and Ed-02-02, showed a decrease in cleaved caspase-3 staining compared to patient lines C9-02-02 and C9-02-03 ( Fig. 5A , p < 0.001).
We have previously reported that the C9orf72 iPSC-derived motor neurons show a reproducible increase in markers of cellular stress, including a higher frequency of PABP positive stress granules. Compared to C902-02 and C9-02-03 lines, the number of polyA-binding protein (PABP) positive stress granules in Ed-02-01 and Ed-02-02 iPSC-derived MNs was restored to levels similar to control lines (Fig. 5B , p < 0.001). and these did not differ between groups (p > 0.05). Further quality control was performed by the addition of "sequin" spike-ins that showed a good correlation between actual and predicted concentrations (Suppl. Fig. 2A ).
RNA sequencing confirms
On exploratory data analysis, there was separation between C9-02-02 and edited controls in principal component 1, after correcting for operator batch effect in the model (Fig. 6A ). Motor neurons from this differentiation had a rostral identity, corresponding to cervical HOX gene expression and in line with other studies (Suppl. Fig. 2B ). Pluripotency markers were not expressed (Suppl. Fig. 2C ) and motor neuron markers were expressed in all cell lines (Suppl. Fig 2D) .
On gene level differential expression analysis, 2220 genes were found differentially expressed at an FDR threshold of 0.05, of these 1017 were upregulated and 1203 were downregulated (Fig. 6B ). Permutation analysis of differential expression was statistically significant (p = 0.027, Fig. 6C ). Total C9orf72 expression was reduced by 22.5% in C9orf72 HRE motor neurons compared to the edited controls, confirming previous qPCR findings (FDR = 0.002, Fig 6D) . Finally, in line with other studies [39] , we detected retention of the repeat containing intron in the C9orf72 HRE positive lines which was restored to lower levels in the edited lines (p = 0.01, Mann-Whitney test , Fig 6 E,F) . On analysis of splicing changes throughout the genome using rMATS (version 4.0.1) no statistically significant differential alternative splicing events were found (p = 0.2).
Enrichment of ALS-relevant pathways including synaptic function in C9orf72
HRE positive motor neurons
Overrepresentation analysis revealed striking differences in up-and downregulated genes. Genes upregulated in C9orf72 HRE positive motor neurons were enriched for calcium-ion dependent exocytosis, synapse organization and neurotransmitter transport, whereas downregulated genes were enriched for cell division (Fig 7A) .
To corroborate these findings using a different method that does not depend on a pvalue threshold, geneset enrichment analysis using the reactome database was performed. The top terms enriched in motor neurons from C9orf72 HRE carriers included Ras activation upon Ca 2+ influx and neurotransmitter release (Suppl. Fig.   3A ). Interestingly, the KEGG Pathway for amyotrophic lateral sclerosis was also enriched in C9orf72 HRE positive iPSMNs (adjusted p-value 0.03). The pathway contains genes involved in a number of ALS relevant pathogenic processes such as glutamate toxicity, mitochondrial dysfunction, ubiquitin proteasome dysfunction as well as neurofilament damage (Suppl. Fig. 3B ). Leading edge analysis using all enriched reactome genesets (adjusted p < 0.05) was performed, to look for genes that are enriched in multiple pathways and therefore may be involved in pathway regulation (Suppl. Fig. 3C ). This analysis yielded a group of genes shared by four or more pathways which included AMPA and NMDA glutamate receptor subunits, synaptic genes, neurofilament light chain and Ras nucleotide exchange factors (Suppl. Fig. 4A ). There was strong overlap between these genes and the leading edge of the ALS KEGG pathway (Suppl. Fig. 4B ). Of relevance to functional results indicating caspase3 activation, the KEGG ALS pathway analysis results included an enrichment of ALS-relevant apoptotic pathways including an upregulation of BAX (FDR = 0.04, log2-fold change 0.8).
Validation of the RNA sequencing study by qPCR was undertaken in an expanded sample cohort and confirmed the findings from the sequencing study (Fig. 7B) . For further validation, we focussed on the enrichment of transcripts encoding synaptic proteins in C9orf72 HRE positive motor neurons. The synaptic constituents Synaptotagmin 11 was found to be consistently upregulated in C9orf72 HRE iPSMNs compared to both isogenic controls and healthy controls. Synaptotagmin 11 transcript levels in other C9orf72 HRE positive iPSMN lines (combined data from three clones from three different patients) were similarly elevated ( Fig 7B) .
To study whether the increased levels of Synaptotagmin 11 affect protein expression we performed western blotting on total soluble protein obtained from six independent motor neuron differentiations and were able to confirm increased levels of Synaptotagmin 11 and SV2A in C9-02 iPSMN lines compared to both healthy controls and edited lines (Fig. 7C) , demonstrating that gene editing has restored the expression of these proteins to their baseline levels.
Discussion
Modelling ALS using iPSC-derived motor neurons offers novel opportunities in studying human motor neurons in vitro and has substantially contributed to the understanding of C9orf72 HRE positive ALS [10, 15, 40] . Key challenges in the interpretation of expression changes in iPSC based models include genetic differences between individuals and also biological variance between cell lines from the same individual, which might mask true expression changes related to the disease mutation.
This makes it challenging to relate changes in transcription to cellular phenotypes to individual mutations, and to the underlying pathophysiology of ALS. The complex genetic architecture of ALS, in which even apparently monogenic forms of the disease may have an oligogenic contribution, makes it even more challenging to isolate the specific impact of individual mutations on cellular phenotypes relevant to ALS [41, 42] . Genome editing, particularly using the CRISPR/Cas9 nuclease, provides a method to address these challenges directly by creating isogenic control lines, and has been successfully used to correct ALS-causing point mutations [17] [18] [19] .
The CRISPR/Cas9 system is a very versatile and simple RNA-mediated system for genome editing in diverse cell types and organisms, with the major advantage of the capacity to target virtually any gene in a sequence-dependent manner [43] . Targeting of Cas9 to a specific genomic site is mediated by a 20-nucleotide guide sequence within an associated single guide RNA (sgRNA) which directs the Cas9 to cleave complementary target DNA-sequences adjacent to short sequences known as protospacer-adjacent motifs (PAMs). Cas9 introduces a double-strand break (DSB) 3base pairs upstream of the PAM, which is repaired by either of two pathways, nonhomologous end-joining (NHEJ) which leads to insertion/deletion (indel) mutations of various lengths, or by homology-directed repair (HDR) which can be used to introduce specific mutations or sequences through recombination of the target locus with exogenously supplied DNA 'donor' templates [22] .
Using this approach, Selvaraj et al. have reported the excision of the C9orf72 HRE and its flanking region in three iPSC lines from different patients demonstrating the correction of neuropathological features in iPSMNs, as also demonstrated in this study [16] . Among several hundred transcriptional changes, they demonstrate increased GluA1 AMPA receptor expression in patient compared to edited lines.
Editing resulted in a reduction of MN-specific vulnerability to excitoxicity. The three lines in the study were corrected using non-homologous end joining, resulting in deletions of variable extent in the promoter region of the most abundant C9orf72 transcript. A second study using a similar approach in two cell lines, demonstrated upregulation of proapoptotic pathways including ATM and p53 that were corrected by excision of the repeat [44] .
Our study uniquely uses homology directed repair to reintroduce a donor template from the other allele, thereby avoiding the deletion of promoter RNA, and leaving behind two short LoxP insertions. We demonstrate that this method results in restoration of normal C9orf72 expression and correction of repeat-associated hypermethylation of CpG islands, as well as in reduced intron retention. Similarly, we also observe an increase in Ca 2+ permeable subunits of AMPA receptors in patient cells, suggesting increased glutamate toxicity.
In line with previous results [10, 44] , this study also demonstrates increased caspase-3 cleavage in C9orf72 HRE positive iPSMNs, which is restored to normal levels after genetic correction. Cleaved caspase-3 is an indicator of ER stress and apoptosis, and has been associated with gain of toxic function in poly-GA overexpressing mouse cortical neurons [45] . The pro-apoptotic milieu associated with the C9orf72 HRE is further corroborated by RNA sequencing results, which show increased BAX expression in patient iPSMNs and is in line with our previous findings of reduced Bcl-2 and increased levels of BIM and Bcl-X L [10] .
In summary, this study provides further evidence for specific pathways underlying the pathogenicity of the C9orf72 HRE expansion by restoring normal cellular phenotypes following focused correction of the expansion using homology directed repair of the Quantification of intron retention of the repeat containing intron divided by the number of reads in the adjacent exon 2 shows reduced intron retention after genome editing (Mean ± SD, p = 0.01, Mann-Whitney test). 
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